Broadfin Capital as of June 30, 2016
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 68 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 11.8 | $121M | 7.4M | 16.47 | |
| Spdr S&p 500 Etf (SPY) | 11.2 | $115M | 550k | 209.47 | |
| Novadaq Technologies | 5.2 | $54M | 5.5M | 9.84 | |
| AngioDynamics (ANGO) | 5.0 | $52M | 3.6M | 14.37 | |
| Retrophin | 4.6 | $47M | 2.7M | 17.81 | |
| Flamel Technologies | 4.6 | $47M | 4.4M | 10.74 | |
| Progenics Pharmaceuticals | 3.7 | $38M | 9.0M | 4.22 | |
| Raptor Pharmaceutical | 3.4 | $35M | 6.5M | 5.37 | |
| Nevro (NVRO) | 2.8 | $29M | 392k | 73.76 | |
| Lion Biotechnologies | 2.5 | $26M | 3.2M | 8.10 | |
| Cardiovascular Systems | 2.2 | $23M | 1.2M | 18.37 | |
| Heron Therapeutics (HRTX) | 2.2 | $23M | 1.3M | 18.05 | |
| Aratana Therapeutics | 2.1 | $22M | 3.4M | 6.32 | |
| La Jolla Pharmaceuticl Com Par | 2.0 | $21M | 1.3M | 16.00 | |
| Endo International | 1.9 | $19M | 1.2M | 15.59 | |
| Medgenics | 1.8 | $19M | 3.4M | 5.55 | |
| Teligent | 1.8 | $18M | 2.5M | 7.14 | |
| Recro Pharma | 1.6 | $16M | 2.1M | 7.95 | |
| Antares Pharma | 1.5 | $16M | 15M | 1.05 | |
| Advaxis | 1.3 | $14M | 1.7M | 8.09 | |
| Aralez Pharmaceuticals | 1.3 | $14M | 4.1M | 3.30 | |
| Endologix | 1.2 | $13M | 1.0M | 12.46 | |
| BioDelivery Sciences International | 1.2 | $12M | 5.2M | 2.36 | |
| Ignyta | 1.2 | $12M | 2.3M | 5.42 | |
| Seaspine Holdings | 1.1 | $12M | 1.1M | 10.48 | |
| Paratek Pharmaceuticals | 1.1 | $11M | 803k | 13.91 | |
| Amarin Corporation | 1.0 | $10M | 4.7M | 2.16 | |
| Derma Sciences | 1.0 | $10M | 2.6M | 3.94 | |
| Intersect Ent | 0.9 | $9.2M | 711k | 12.93 | |
| Ophthotech | 0.9 | $9.1M | 177k | 51.03 | |
| Medicines Company | 0.8 | $8.6M | 256k | 33.63 | |
| Redhill Biopharma Ltd cmn | 0.8 | $8.0M | 737k | 10.86 | |
| Dynavax Technologies (DVAX) | 0.8 | $8.0M | 548k | 14.58 | |
| Egalet Corporation note 5.50% 4/1/20 | 0.7 | $7.6M | 10M | 0.76 | |
| Zogenix | 0.7 | $7.1M | 882k | 8.05 | |
| Genomic Health | 0.7 | $7.0M | 270k | 25.89 | |
| Alcobra | 0.7 | $7.0M | 1.6M | 4.49 | |
| Corium Intl | 0.7 | $6.7M | 1.9M | 3.47 | |
| Adma Biologics (ADMA) | 0.6 | $6.6M | 1.1M | 5.95 | |
| Strongbridge Bioph shs usd | 0.6 | $6.6M | 1.7M | 3.98 | |
| DepoMed | 0.6 | $6.4M | 325k | 19.62 | |
| Qlt | 0.6 | $6.3M | 4.4M | 1.42 | |
| Aegerion Pharmaceuticals | 0.6 | $6.0M | 4.0M | 1.49 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.6 | $5.8M | 8.2M | 0.71 | |
| Egalet | 0.6 | $5.6M | 1.1M | 4.96 | |
| Tenax Therapeutics | 0.5 | $5.0M | 2.0M | 2.56 | |
| Aviragen Therapeutics | 0.5 | $4.9M | 3.5M | 1.40 | |
| Idera Pharmaceuticals | 0.5 | $4.7M | 3.1M | 1.53 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.5 | $4.6M | 1.0M | 4.64 | |
| Mediwound Ltd cmn | 0.4 | $4.2M | 531k | 7.89 | |
| Mirati Therapeutics | 0.4 | $3.8M | 694k | 5.46 | |
| Anthera Pharmaceutcls | 0.3 | $3.6M | 1.2M | 3.09 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.3 | $3.6M | 16M | 0.23 | |
| DURECT Corporation | 0.3 | $3.5M | 2.9M | 1.22 | |
| Pacira Pharmaceuticals (PCRX) | 0.3 | $3.1M | 93k | 33.73 | |
| Scynexis | 0.3 | $3.2M | 1.5M | 2.17 | |
| Trevena | 0.3 | $3.1M | 492k | 6.30 | |
| Contrafect | 0.2 | $1.9M | 653k | 2.89 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $1.7M | 167k | 10.31 | |
| CAS Medical Systems | 0.1 | $1.5M | 811k | 1.84 | |
| Windtree Therapeutics | 0.1 | $1.5M | 778k | 1.93 | |
| Dextera Surgical | 0.1 | $1.6M | 863k | 1.80 | |
| Protalix BioTherapeutics | 0.1 | $1.3M | 2.0M | 0.64 | |
| Ritter Pharmaceuticals | 0.1 | $1.2M | 768k | 1.53 | |
| Rxi Pharmaceuticals Corp | 0.1 | $1.2M | 488k | 2.40 | |
| Tonix Pharmaceuticls | 0.1 | $864k | 434k | 1.99 | |
| Strata Skin Sciences Incorporated | 0.1 | $587k | 961k | 0.61 | |
| Dipexium Pharmaceuticals | 0.0 | $444k | 45k | 9.92 |
